ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

ConvaTec Group Plc

ConvaTec is a medical products and technologies company that develops, manufactures, and markets products for the management of chronic conditions, with a focus on advanced wound care, ostomy care, continence and critical care, and infusion care.

ConvaTec

Convatec Infusion Care

Convatec Ostomy Care

Convatec Nederland

Flexi-Seal™ Fecal Management System

Convatec Continence Care

Convatec Wound

Clínica ConvaCare

At Convatec, #ForeverCaring is our promise to patients & healthcare providers, as we deliver pioneering trusted medical solutions to improve the lives we touch. 

#ForeverConvatec

Convatec

Hidden health conditions are not always immediately obvious to others, but the more you understand about them, the more people feel seen. 

At Convatec we are on a journey to Forever caring, find out more here: https://lnkd.in/eUKmshiy 

#ForeverCaring #ForeverConvatec #HiddenHealthConditions

This week, colleagues at our largest UK manufacturing site in Deeside, north Wales were pleased to host a visit from the local Member of Parliament, the Rt Hon Mark Tami. During his visit, Mark met colleagues and was given a demonstration of our different products and solutions in advanced wound care, as well as a tour of our facilities including our textile line and new clean room.
 
Our CFO Jonny Mason and UK manufacturing site leader Adeel Mushtaq enjoyed hosting Mark, alongside other leaders in research and development and operations. Mark was also able to spend time with several of our apprentices and summer interns to hear more about how our teams are bringing to life our vision of pioneering trusted medical solutions to improve the lives we touch. 

#ForeverCaring #ForeverConvatec #WeAreConvatec #Deeside

Today, on World Humanitarian Day, we recognise the important role of humanitarian workers in delivering life-saving support and protection to those who need it most. 

In line with our forever caring promise, we also support humanitarian partners who serve vulnerable populations in our communities. This year we contributed to relief efforts around the catastrophic flooding in South Brazil, and the devastating earthquake in Japan. We also continued to support our charity partners working in Ukraine, with additional product donations bringing our total contribution to over $2 million.

In addition, we take this moment to thank our global charity partner, Partners In Health (PIH). Through our partnership, PIH has facilitated the training and equipping of hundreds of Community Health Workers (CHW), which by extension, have touched the lives of thousands of people. 

#WorldHumanitarianDay #ConvateCares #PIH 
#WeAreConvatec #ForeverCaring #ForeverConvatec

Hidden health conditions are more common than you may think, and many people don’t know much about them at all.
 
Find out more about how Convatec can support you here: https://lnkd.in/eUKmshiy
 
#ForeverCaring #ForeverConvatec #HiddenHealthConditions

Starting your treatment doesn’t have to stop you from doing the things you love. Re-define your diagnosis.
 
#ForeverCaring #ForeverConvatec

msh id	COM:CONVATECGROUP
symbol	CTEC
name	ConvaTec Group Plc
homepage url	https://www.convatecgroup.com
country	GB
sector	Healthcare
industry	Medical - Instruments & Supplies
market	STOCKS
employee count	10.14K
crunchbase url	-
linkedin url	-
founders	-

market cap	64.2M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-0.04
growth cost of revenue	-0.01
growth depreciation and amortization	0.23
growth ebitda	0.12
growth ebitda ratio	0.09
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.04
growth gross profit	0.07
growth gross profit ratio	0.04

COM:CONVATECGROUP

ConvaTec

Last Close

233.00

21/11 16:35

Market Cap

49.54M

Beta: -

Volume Today

4.48M

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	1.88B
cost of revenue	1.88B
depreciation and amortization	214.8M
ebitda	482.2M
ebitda ratio	0.23
eps	0.06
eps diluted	0.06
operating expenses	935.4M
operating income	262.7M
operating income ratio	0.12

accounts receivables	-
capital expenditure	-129.2M
cash at beginning of period	143.8M
cash at end of period	97.6M
inventory	396.1M
working capital ttm	375.2M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-